缺血性中风重症患者的基数过剩和死亡率之间的关联:一个回顾性队列研究
Jueheng Liu1, Jiamei Li1, Xuting Jin1
1Department of Critical Care Medicine, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
BMC neurology
|September 18, 2024
概括
进入ICU的危急性缺血性中风患者的低基过量 (BE) 与较高的死亡率有关. 这一发现突出了BE作为潜在的中风预后标志物.
科学领域:
- 关键护理医学 关键护理医学
- 神经学 神经学
- 生物化学 生物化学
背景情况:
- 基过量 (BE) 是各种疾病中已知的死亡率预测因素.
- 在缺血性中风患者中BE的预后意义仍然不清楚.
- 这项研究研究了初始BE水平与重症中风患者的死亡率之间的关联.
研究的目的:
- 为了确定入院基数过剩 (BE) 与重症监护室 (ICU) 缺血性中风患者的死亡率之间的关系.
- 评估BE对短期 (ICU,医院,28天) 和长期 (1年) 死亡率的影响.
- 探索顺序性器官衰竭评估 (SOFA) 评分对BE的预后价值的影响.
主要方法:
- 分析了1572名缺血性中风患者的队列.
- 多变量逻辑回归和考克斯比例危险模型评估了BE和死亡率之间的关联.
- 相互作用和子组分析通过SOFA评分 (≥5比<5) 评估了效果修改.
主要成果:
- 在BE和死亡风险之间观察到U形关系.
- 低BE (<-3 mmol/L) 与急症监护室,医院,28天和1年死亡率的增加显著相关.
- 这些关联在不同的SOFA分数层中保持一致.
结论:
- 在ICU入院时,初始基数过剩 (BE) < -3 mmol/L 是危急性缺血性中风患者死亡率增加的重要预测因素.
- 在这个人群中,BE作为短期和长期结果的有价值的预后指标.
- 根据SOFA评分,无论疾病的严重程度如何,BE的预后效用是显而易见的.
相关概念视频
Life Tables
674
A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
674
Actuarial Approach
384
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
384
Kaplan-Meier Approach
792
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
792
Assumptions of Survival Analysis
492
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
492
Comparing the Survival Analysis of Two or More Groups
712
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
712
Hazard Rate
525
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
525


